Fosaprepitant for nausea in the emergency room
Treatments studied
Part of Digestive system clinical trials.
This study tests if a drug called fosaprepitant can help people in the emergency room whose nausea and vomiting don't improve with standard medicine. It may be an option if you still feel sick 2 hours after your first nausea treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are currently in the emergency department for nausea or vomiting.
- You haven't taken any nausea medication in the last 2 hours.
- You are not pregnant, trying to get pregnant, or breastfeeding.
- You do not have a slow heart rate or a known heart rhythm problem.
- You speak English or Spanish and have a phone for follow-up communication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medications to see which works better to reduce nausea and vomiting in the emergency department. Both drugs are commonly used for nausea, and the trial aims to find the most effective one for you.
This study tests whether the combination of olanzapine and metoclopramide can prevent nausea and vomiting caused by strong painkillers (opioids) in people with advanced cancer. If you are starting a strong opioid for pain and have not had nausea or vomiting recently, this study may be for you.
This trial studies whether palonosetron helps prevent nausea and vomiting caused by chemotherapy that has a moderate risk of vomiting. It may help you feel more comfortable during chemo and avoid treatment interruptions from severe nausea.
This trial tests a medicine called IV NEPA (fosnetupitant/palonosetron) to prevent nausea and vomiting in children who are receiving strong chemotherapy. Patients will receive at least one cycle of chemotherapy that is highly likely to cause these side effects.
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
This study compares two ways of giving anti-nausea medication: one through an IV (drip) and one as a pill. Both are paired with a newer drug to prevent nausea and vomiting caused by chemotherapy in breast cancer patients.
Hear when a new Nausea and Vomiting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.